This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Bucket Trial

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Bucket Trials Mean in Everyday Medical Language

A bucket trial, also known as a basket trial, is a type of clinical study that tests a new drug or treatment in patients whose cancers have a shared genetic mutation or biomarker, even if the cancers started in different parts of the body. Instead of grouping patients by where their cancer began—such as lung, breast, or colon cancer—these trials group patients by a specific change found in their cancer cells. Everyone in the trial receives the same treatment designed to target that particular mutation or biomarker.

Why Bucket Trials Matter in Cancer Care

This approach is important because many cancers have unique genetic changes that can be targeted by new drugs. Bucket trials allow researchers to test these targeted treatments across various cancer types at once. This can be especially helpful for studying rare cancers or uncommon genetic changes that might not have enough patients for traditional trials focused on one cancer type. By grouping patients this way, bucket trials may help speed up the development and approval of new treatments, offering more opportunities for patients to try therapies based on the specific features of their cancer.

What Patients Might See or Hear About Bucket Trials

If your doctor talks about a bucket trial, it might be because genetic testing of your cancer found a specific mutation that makes you eligible for a study testing a drug aimed at that mutation. You may be invited to join such a trial if standard treatments are not effective or if your doctor thinks the targeted treatment might help. Information about bucket trials can appear in clinical trial listings, treatment plans, or discussions about personalized cancer care.

What Bucket Trials Do Not Automatically Mean

Being eligible for a bucket trial does not guarantee that the treatment will work for you or that it is approved as standard care. These trials are research studies designed to find out if the treatment is safe and effective for people with that mutation. The term does not mean the cancer is cured or that the treatment is already widely used. It is important to understand that bucket trials are part of ongoing research and testing.

Common Questions to Ask Your Care Team

If you hear about a bucket trial, it can be helpful to ask your care team questions such as: What mutation does my cancer have? How does this trial’s treatment target that mutation? What are the possible benefits and risks? How does this trial compare to other treatment options? Your doctors can help explain whether a bucket trial might be a good option for you and guide you through the process if you choose to participate.

Understanding Bucket Trials in the Context of Personalized Medicine

Bucket trials are closely linked to concepts like biomarkers, targeted therapy, and precision medicine. These ideas focus on tailoring treatment to the specific characteristics of a person’s cancer rather than just the cancer’s location in the body. Precision medicine uses information about genetic changes in tumors to help guide treatment choices, and bucket trials are one way to test treatments based on these genetic features.

Next Steps for Patients and Caregivers

If you think a bucket trial might be an option for you, the next step is to talk with your cancer care team about your genetic testing results and whether any trials are available that match your cancer’s specific changes. Your care team can help explain the potential benefits and risks and support you in making informed decisions about your treatment and participation in clinical research.

Sources

Public source information used for this glossary entry includes: